A protocol for testing the stability of biochemical analytes. Technical document

被引:33
作者
Gomez-Rioja, Ruben [1 ]
Segovia Amaro, Marta [1 ]
Diaz-Garzon, Jorge [1 ]
Miquel Bauca, Josep [2 ]
Martinez Espartosa, Debora [3 ]
Fernandez-Calle, Pilar [1 ]
Garralda, Andrea Caballero
Ibarz, Mercedes
Llopis, Maria Antonia
Marzana, Itziar
Ventura, Monserrat
del Pino, Isabel Garcia
Gomez, Carolina
Puente, Juan Jose
Aguila, Carmen Ricos
Alsina, Carmen Perich
Minchinela, Joana
Simon, Margarita
Lario, Jose Vicente Garcia
Juliani, Beatriz Boned
Fernandez, Pilar Fernandez
Lao, Elisabet Gonzalez
Cortes, Zoraida
Garcia, Fernando Marques
Ganduxe, Xavier Tejedor
Marco, Jorge Diaz-Garzon
机构
[1] La Paz Cantoblanco Carlos III Univ Hosp, Lab Med Dept, Paseo Castellana 261, Madrid 28046, Spain
[2] Hosp Univ Son Espases, Lab Med Dept, Palma De Mallorca, Spain
[3] Clin Univ Navarra, Lab Dept, Madrid, Spain
关键词
guideline; preanalitycal phase; sample stability; WHOLE-BLOOD; CLINICAL-CHEMISTRY; TEMPERATURE; PLASMA; HORMONE; SERUM; TIME; SAMPLES; DRUGS; TUBES;
D O I
10.1515/cclm-2019-0586
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Stability of a measurand in a specimen is a function of the property variation over time in specific storage conditions, which can be expressed as a stability equation, and is usually simplified to stability limits (SLs). Stability studies show differences or even inconsistent results due to the lack of standardized experimental designs and heterogeneity of the chosen specifications. Although guidelines for the validation of sample collection tubes have been published recently, the measurand stability evaluation is not addressed. This document provides an easy guideline for the development of a stability test protocol based on a two-step process. A preliminary test is proposed to evaluate the stability under laboratory habitual conditions. The loss of stability is assessed by comparing measurement values of two samples obtained from the same patient and analyzed at different time points. One of them is analyzed under optimal conditions (basal sample). The other is stored under specific stability conditions for a time set by the laboratory (test sample). Differences are expressed using percentage deviation (PD%) to facilitate comparison with specifications. When the preliminary test demonstrates instability, a comprehensive test is proposed in order to define the stability equation and to specify SLs. Several samples are collected from a set of patients. The basal sample is analyzed under optimal conditions, whereas analysis of test samples is delayed at time intervals. For each patient PD% is calculated as the difference between measurements for every test sample and its basal one and represented in a coordinate graph versus time.
引用
收藏
页码:1829 / 1836
页数:8
相关论文
共 37 条
  • [1] The Biological Variation Data Critical Appraisal Checklist: A Standard for Evaluating Studies on Biological Variation
    Aarsand, Aasne K.
    Roraas, Thomas
    Fernandez-Calle, Pilar
    Ricos, Carmen
    Diaz-Garzon, Jorge
    Jonker, Niels
    Perich, Carmen
    Gonzalez-Lao, Elisabet
    Carobene, Anna
    Minchinela, Joana
    Coskun, Abdurrahman
    Simon, Margarita
    Alvarez, Virtudes
    Bartlett, William A.
    Fernandez-Fernandez, Pilar
    Boned, Beatriz
    Braga, Federica
    Corte, Zoraida
    Aslan, Berna
    Sandberg, Sverre
    [J]. CLINICAL CHEMISTRY, 2018, 64 (03) : 501 - 514
  • [2] Alsina MJ, 2006, QUIM CLIN, V25, P86
  • [3] [Anonymous], 151892012 UNEEN ISO
  • [4] [Anonymous], 2010, GP44A4 CLSI
  • [5] [Anonymous], 2010, GP34A CLSI
  • [6] [Anonymous], 2004, GP43A4 CLSI
  • [7] Stability of Po2, Pco2, and pH in fresh blood samples stored in a plastic syringe with low heparin in relation to various blood-gas and hematological parameters
    Beaulieu, M
    Lapointe, Y
    Vinet, B
    [J]. CLINICAL BIOCHEMISTRY, 1999, 32 (02) : 101 - 107
  • [8] Factors affecting the stability of drugs and drug metabolites in biological matrices
    Briscoe, Chad J.
    Hage, David S.
    [J]. BIOANALYSIS, 2009, 1 (01) : 205 - 220
  • [9] CALAM RR, 1988, J CLIN IMMUNOASSAY, V11, P86
  • [10] CLSI, 2009, GP16A3 CLSI, V3rd